# Crescent (CBIO) — Earnings

CBIO · NASDAQ · Stock

Canonical page: https://www.lighthorse.io/tickers/cbio/earnings

## Most recent quarter

| Metric | Value |
| --- | --- |
| Fiscal period | Q2 2025 |
| Period end | Jun 30, 2025 |
| EPS actual | −$4.93 |
| EPS estimate | −$1.67 |
| EPS surprise | −195.71% |
| Revenue surprise | +0.00% |
| Revenue | $0.00 |
| Revenue estimate | $0.00 |
| Reported | Jul 31, 2025 |
| SEC filing | [View filing](https://www.sec.gov:443/Archives/edgar/data/1253689/000162828025036839/cbio-20250630.htm) |

## Earnings history

| Fiscal period | Report date | EPS estimate | EPS actual | Surprise | Revenue estimate | Revenue actual |
| --- | --- | --- | --- | --- | --- | --- |
| Q2 2025 | Jul 31, 2025 | −$1.67 | −$4.93 | -195.71% | — | — |
| Q1 2025 | May 14, 2025 | −$5.00 | −$17.82 | -256.40% | — | — |
| Q1 2024 | May 9, 2024 | −$16.00 | −$17.00 | -6.25% | — | — |
| Q4 2023 | Mar 27, 2024 | −$15.25 | −$14.00 | 8.20% | — | $10,000.00 |
| Q3 2023 | Nov 3, 2023 | −$14.33 | −$14.00 | 2.33% | — | — |
| Q2 2023 | Aug 2, 2023 | −$18.33 | −$13.00 | 29.09% | $50,000.00 | — |
| Q1 2023 | May 3, 2023 | −$16.67 | −$17.00 | -2.00% | — | — |
| Q4 2022 | Mar 29, 2023 | −$16.67 | −$19.00 | -14.00% | — | — |
| Q3 2022 | Nov 9, 2022 | −$25.00 | −$16.00 | 36.00% | — | — |
| Q2 2022 | Aug 3, 2022 | −$28.50 | −$25.00 | 12.28% | — | $75,000.00 |
| Q1 2022 | Apr 28, 2022 | −$32.75 | −$28.00 | 14.50% | — | — |
| Q4 2021 | Mar 3, 2022 | −$34.25 | −$33.00 | 3.65% | — | $18,000.00 |
| Q3 2021 | Nov 2, 2021 | −$31.75 | −$34.00 | -7.09% | — | $87,000.00 |
| Q2 2021 | Aug 5, 2021 | −$30.75 | −$28.00 | 8.94% | — | $1,000.00 |
| Q1 2021 | May 3, 2021 | −$31.00 | −$28.00 | 9.68% | — | $1.1M |
| Q4 2020 | Mar 2, 2021 | −$31.40 | −$32.00 | -1.91% | $333,333.00 | $163,000.00 |
| Q3 2020 | Nov 6, 2020 | −$32.00 | −$29.00 | 9.38% | — | $1.0M |
| Q2 2020 | Jul 31, 2020 | −$37.20 | −$32.00 | 13.98% | — | — |
| Q1 2020 | May 1, 2020 | −$29.60 | −$18.00 | 39.19% | — | $9.0M |

## Frequently Asked Questions

### When did Crescent (CBIO) last report earnings?

Crescent last reported on Jul 31, 2025, covering fiscal Q2 2025.

### Did CBIO beat earnings estimates?

No. Crescent reported EPS of −$4.93 for Q2 2025 against a −$1.67 estimate — a 195.71% miss.

---

Earnings figures may be restated, revised or corrected by the issuer. Past results do not indicate future performance.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.

Data provided by [AInvest](https://www.ainvest.com).